RE: Blood Test Might Spot Alzheimer''''s Early
Thanks for the great article.
" "Because we don't have a marker that predicts [Alzheimer's] right now, such a trial is almost prohibitively expensive," he said --
askretka....."TTH's and Elan's phase III costs just got a whole lot cheaper and TTH's cost to get their 50% stake just got a lot cheaper as well I would guess." ........"This new alzheimer's blood test will make the screening process for potential patients a lot faster and cheaper."
That would be great al....... Recall that Elan and Transition set up the $200 Million WW Collaberation in such a way that Transition will not have to put up a single dollar of their own to complete the Trials. Milestone and Progress payments will be sufficient to cover all of Transitions share of the developmental costs.
Of course the $15 million Upfront Payment from Elan was not included in the calculations. That goes straight into the Transition Vault.
So if Transition elects to increase its position from 30% up to 50% (Dr. Cruz again reiterated that that is their intention) it could very well be as you say, Much Cheaper for both Transition and Elan. It is my understanding that the testing on these blood tests is moving along very quickly.
Transition and Elan are using all sorts of bio-markers to trace AZD-103 in the Human Body. To be able to have one to help with enrolling patients used in conjunction with the current standard testing would speed things up a lot!!
Good luck all.